Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 7,175 calls trading, 1.0x expected, and implied vol increasing almost 2 points to 103.07%. Jan-26 10 calls and Jul-25 5.5 calls are the most active options, with total volume in those strikes near 2,300 contracts. The Put/Call Ratio is 0.24. Earnings are expected on August 7th.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Nvidia hits $4T market cap, Merck acquires Verona Pharma: Morning Buzz
- Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement
- Recursion Pharmaceuticals call volume above normal and directionally bullish
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Strategic Acquisition and Market Positioning Drive Buy Rating for Recursion Pharmaceuticals